LexDanaLexDanabeta
Inventor

Galen Paul SHEARN-NANCE

Inventor
US

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry9%
C07KPeptides9%
PatentTitleYear
12,528,786Plasma kallikrein inhibitors202612,459,927Plasma kallikrein inhibitors202511,739,101Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to GILEAD SCIENCES INC (1)· patent assignee history
2023Patents assigned to NURIX THERAPEUTICS INC (1)· patent assignee history
2023–2026Based in US· patent location history
2025–2026Patents assigned to MERCK SHARP & DOHME LLC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME LLC22025–2026
GILEAD SCIENCES INC12023
NURIX THERAPEUTICS INC12023
Locations
LocationPatentsSpan
US32023–2026